Current Research Studies
A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature
BMN-111-210 Vosoritide
What is the goal of the study?
Study 111-210 is a Phase 2, randomized, multicenter study of vosoritide in children with Idiopathic Short Stature (ISS) who are naïve to growth hormone treatment, intended to characterize the short-term efficacy and safety of 3 dosing regimens of vosoritide in reference to placebo in a blinded setting (in the Dose-Finding Phase), and to provide a long-term efficacy and safety assessment of the therapeutic dose of vosoritide versus human growth hormone (hGH) in an open-label setting (in the Long-Term Phase).
Who can participate in the study?
Please contact the study team listed below to learn more.